TABLE 1 from Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC | Synapse
March 14, 2024Open Access
TABLE 1 from Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC
Key Points
Key points are not available for this paper at this time.
Abstract
Baseline characteristics of patients with ALK-positive NSCLC in clinical cohort by EML4-ALK v1 and v3 subgroups